Literature DB >> 6837660

Antepartum chronic fetal vesicoamniotic shunts for obstructive uropathy: A report of two cases.

F A Manning, C R Harman, I R Lange, R Brown, A Decter, N MacDonald.   

Abstract

Two fetuses with obstructive uropathy characterized by striking oligohydramnios and dilatation of the urinary collecting system were identified by ultrasound and treated by percutaneous insertion of a long-term vesicoamniotic silicone rubber shunt. Both fetuses were less than 16 weeks' gestation at diagnosis and less than 18 weeks at treatment. One fetus was delivered at 35 weeks and is alive and well; the other died early in the neonatal period at 31 weeks with pulmonary hypoplasia.

Entities:  

Mesh:

Year:  1983        PMID: 6837660     DOI: 10.1016/0002-9378(83)90685-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Ultrasonographic anatomy and diagnosis of fetal uropathies affecting the upper urinary tract. II. Nonobstructive uropathies.

Authors:  J M Duval; J Milon; Y Coadou; J M Blouet; B Langella; T Bourgin; J C Nicolas; B Fremond; J C Duval; H Jouan
Journal:  Surg Radiol Anat       Date:  1986       Impact factor: 1.246

2.  Obstruction of the fetal urinary tract: a role for surgical intervention in utero?

Authors:  I R McFadyen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

3.  Obstruction of the fetal urinary tract: a role for surgical intervention in utero?

Authors:  I R McFadyen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

4.  Neonatal outcome of fetuses with urinary tract abnormalities diagnosed by prenatal ultrasonography.

Authors:  B T Steele; J De Maria; A Toi; A Stafford; D Hunter; C Caco
Journal:  CMAJ       Date:  1987-07-15       Impact factor: 8.262

5.  Postnatal Management in Congenital Lower Urinary Tract Obstruction With and Without Prenatal Vesicoamniotic Shunt.

Authors:  Marietta Jank; Raimund Stein; Nina Younsi
Journal:  Front Pediatr       Date:  2021-04-14       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.